红景天苷
脉络膜新生血管
免疫印迹
基质凝胶
化学
血管内皮生长因子
体外
缺氧诱导因子
血管生成
新生血管
医学
缺氧(环境)
癌症研究
血管内皮生长因子受体
免疫学
男科
药理学
黄斑变性
眼科
分子生物学
生物
生物化学
基因
氧气
有机化学
作者
Haitao Yang,Qingwu Yang,Linfei Zheng
标识
DOI:10.1080/15569527.2021.1973023
摘要
PURPOSE: As a characteristic of age-related macular degeneration (AMD), choroidal neovascularization (CNV) causes severe vision loss. The current treatment has limited efficacy. This study was to investigate effects of Salidroside against CNV and explore its underlying mechanisms. METHODS: ) for 6 hr to mimic hypoxic condition. Cells were then treated with Salidroside at 10, 30, and 100 µM for 24 hr. Cells treated with DMSO were used as negative control. The cell proliferation was assessed using 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium-bromid assay. The tube formation was investigated on Matrigel. The cell migration was measured by a Transwell assay. RT-qPCR was used to detect the gene expression. Immuohistochemistry and western blot were used to detect the expression of proteins. RESULTS: Salidroside significantly inhibited the cell migration and tube formation activity of RF/6A cells under hypoxia. Moreover, Salidroside reduced the expression levels of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1 (HIF-1) in RF/6A cells. CONCLUSIONS: Our data suggested that Salidroside could be a potential novel therapeutic agent against CNV.
科研通智能强力驱动
Strongly Powered by AbleSci AI